| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/26/2002 | US20020137790 Method for the production and use of a cream containing vitamin-A |
| 09/26/2002 | US20020137789 Anticancer agents |
| 09/26/2002 | US20020137788 Coniosetin and derivatives thereof, process for the preparation and the use thereof |
| 09/26/2002 | US20020137787 Prevention or treatment of complications related to non-insulin dependent diabetes mellitus or type 2 diabetes mellitus |
| 09/26/2002 | US20020137786 Deprenyl compounds to treat viral infections and reduce tissue damage associated therewith |
| 09/26/2002 | US20020137785 Inflammatory mechanism modulator composition and methods with anti-asthmatic properties |
| 09/26/2002 | US20020137782 Amide substituted benzimidazole or benzoxazole; regulating the interaction of vascular cell adhesion molecule-1 and fibronectin with the integrin vascular cell adhesion molecule very late antigen-4 |
| 09/26/2002 | US20020137781 Pesticides |
| 09/26/2002 | US20020137780 Differentiating agents for the treatment of inflammatory intestinal diseases |
| 09/26/2002 | US20020137778 Anticancer, antiarthritic, and antiinflammatory agents |
| 09/26/2002 | US20020137777 Benzothiazole, riluzole, phenylbenzothiazole or lifarizine as blocking agents to limit sodium/calcium exchange in the retinal ganglion cells |
| 09/26/2002 | US20020137776 Therapeutic and prophylactic agents for neoplasms |
| 09/26/2002 | US20020137773 Nontoxic insulin sensitizers troglitazone, ciglitazone, rosglitazone, pioglitazone or englitazone |
| 09/26/2002 | US20020137772 Administering nontoxic insulin sensitiser and a biguanide antihyperglycaemic agent |
| 09/26/2002 | US20020137771 Mixing benzimidazole derivatives with basic inorganic salt stabilizing agent, granulating and enteric coating granules; gastric acid secretion inhibitors |
| 09/26/2002 | US20020137770 Piperidine derivatives |
| 09/26/2002 | US20020137769 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
| 09/26/2002 | US20020137768 Methods for treating disorders using norastemizole in combination with other active ingredients |
| 09/26/2002 | US20020137767 (+)-1-(1-(2-chlorophenyl)cyclopropyl)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline D1/D5 antagonist or partial agonist |
| 09/26/2002 | US20020137766 Electrophysiological activity |
| 09/26/2002 | US20020137765 Sustained release formulations for growth hormone secretagogues |
| 09/26/2002 | US20020137764 .0005-5 wt% of a tiotropium salt, an antiallergic, antihistamine, steroid, or leukotriene antagonist, water or water/ethanol mixture and a preservative; antiasthmatics and chronic obstructive pulmonary disease treatment |
| 09/26/2002 | US20020137763 (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione |
| 09/26/2002 | US20020137761 Treating tolerance or drug addiction; analgesics |
| 09/26/2002 | US20020137760 Antipruritic |
| 09/26/2002 | US20020137758 Use caffeine and alcohol following a stroke to reduce cerebral infarct damage and improve the chances for complete recovery |
| 09/26/2002 | US20020137757 Quinazolines and therapeutic use thereof |
| 09/26/2002 | US20020137755 Tyrosine kinase inhibitors |
| 09/26/2002 | US20020137752 Gemifloxacin compound |
| 09/26/2002 | US20020137751 Method of treatment |
| 09/26/2002 | US20020137749 Formulation for menopausal women |
| 09/26/2002 | US20020137748 Reducing intestinal toxicity of a noncompetitive thymidylate synthase inhibitor by co-administering a folate derivative without blocking therapy; anticancer, antitumore agents |
| 09/26/2002 | US20020137747 Block cytokine production via inhibition of p38 kinase; triamino-s-triazine compounds; treating rheumatoid arthritis |
| 09/26/2002 | US20020137746 Prostaglandin E2 membrane-bound receptor (EP1); for example, 2-(4-sodium carboxyphenyl),3-((2-(benzyloxy)phenyl)-thiophene |
| 09/26/2002 | US20020137745 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease |
| 09/26/2002 | US20020137744 Metalloprotease inhibitors |
| 09/26/2002 | US20020137743 N-(phenylacetyl)alanine, isobutyl ester for example; prophylaxis and treatment of Alzheimer's disease |
| 09/26/2002 | US20020137742 Benzenesulfonamide compounds |
| 09/26/2002 | US20020137741 Use as topical antibiotics |
| 09/26/2002 | US20020137740 CRF (corticotropin releasing factor) antagonists; 4-(2-Chloro-4-methoxyphenyl)-5-methyl-2-(N-(5-ethoxy-carbonyl-2 -methoxyphenyl)-N-propylamino)thiazole for example |
| 09/26/2002 | US20020137739 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
| 09/26/2002 | US20020137738 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 09/26/2002 | US20020137737 1-(3-methyl-1-(1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4 -benzodiazepin-3-ylcarbamoyl)-butyl)-cyclopent-3-enecarboxylic amide, for example; gamma-secretase inhibitors; Alzhemier's disease, Down's Syndrome |
| 09/26/2002 | US20020137735 Therapy of auto-immune disease by a photochemotherapeutical method |
| 09/26/2002 | US20020137733 Macrocyclic anti-viral compounds |
| 09/26/2002 | US20020137732 Small molecule inhibitors targeted at Bcl-2 |
| 09/26/2002 | US20020137729 For minimizing the absorption of triglycerides and fats in the gastrointestinal tract; fat binding; treating obesity |
| 09/26/2002 | US20020137727 Forming a powder blend of active ingredient with diluents, wet granulating with water, compressing the lubricated granule mixture into tablet form; alendronic acid dosage forms |
| 09/26/2002 | US20020137726 Aryl phosphate derivatives of D4T with potent anti-viral activity |
| 09/26/2002 | US20020137725 Use of tagatose in promoting cardiovascular health |
| 09/26/2002 | US20020137724 Oral composition containing NSAIDs and essential oils |
| 09/26/2002 | US20020137723 Low molecular weight polymannuronate |
| 09/26/2002 | US20020137722 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| 09/26/2002 | US20020137721 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 09/26/2002 | US20020137718 Nucleozymes |
| 09/26/2002 | US20020137717 Use of chimeric mutational vectors to change endogenous nucleotide sequences in solid tissues |
| 09/26/2002 | US20020137716 Administering nucleotide sequence |
| 09/26/2002 | US20020137714 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 09/26/2002 | US20020137704 Aids therapy; administering enzyme inhibitor |
| 09/26/2002 | US20020137700 Nucleic acids; genetic engineering |
| 09/26/2002 | US20020137696 Specific modulation of TH1/TH2 cytokine expression by ribavirin in activated T-lymphocytes |
| 09/26/2002 | US20020137695 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels |
| 09/26/2002 | US20020137693 Comprising an admixture of a natural inhibitor of epidermal growth factor receptor (EGFR) activation or a derivative or analog and a dermatological carrier; antipeeling agents; genistein and other isoflavones and other plant extracts |
| 09/26/2002 | US20020137692 Treating and preventing hair loss, i.e., alopecia; using as opener, minoxidil, and as inhibitor, procyanidin B2; kits |
| 09/26/2002 | US20020137691 Supplement collagen and elastic tissues and thicken the dermis; administering a sugar compound converting mucopoly-saccharides; enzyme inhibitor of collangenase/elastase; an amino acid; fat burner, vaso-dilator and chromium picolinate |
| 09/26/2002 | US20020137690 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 09/26/2002 | US20020137689 Hypolipidemic agents |
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity |
| 09/26/2002 | US20020137686 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/26/2002 | US20020137680 Growth factor expression |
| 09/26/2002 | US20020137669 Treatment of dyskinesia |
| 09/26/2002 | US20020137665 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 09/26/2002 | US20020137664 Substituted piperidines as melanocortin-4 receptor agonists |
| 09/26/2002 | US20020137221 Method of preserving oxygen infusions |
| 09/26/2002 | US20020137210 Method for modifying genetic characteristics of an organism |
| 09/26/2002 | US20020137162 Methods and reagents for inhibiting specific histone deacetylase isoforms by inhibiting expression at the nucleic acid level or enzymatic activity at the protein level |
| 09/26/2002 | US20020137155 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher Basidiomycetes mushroom |
| 09/26/2002 | US20020137138 Modulating serotonin activity |
| 09/26/2002 | US20020137129 Polypeptides; genetic engineering; drug development |
| 09/26/2002 | US20020137095 Reelin protein CR-50 epitope region |
| 09/26/2002 | US20020137028 Use of neuronal apoptosis inhibitor protein (naip) |
| 09/26/2002 | US20020136934 Glass-, ceramic- or vitroceramic-based substrate with a coating of partially crystalline titanium dioxide; self-cleaning glazings for vehicles or buildings |
| 09/26/2002 | US20020136910 Deposition of organosilsesquioxane films |
| 09/26/2002 | US20020136819 Conserved concentrations of cocoa polyphenols by mixing carbohydrate or protein containing ingredients with a polyphenol conserving pretreatment ingredient and then with a cocoa polyphenol |
| 09/26/2002 | US20020136787 Method of treating prickly heat |
| 09/26/2002 | US20020136786 Composition and method for smoke detoxification |
| 09/26/2002 | US20020136785 Screening for the active compound of Panax plant berries, which may be a ginsenoside |
| 09/26/2002 | US20020136782 Vitamin B6, zinc, manganese, chromium, gymnema sylvestre leaf and extract, vanadium, glucosamine sulfate, lipotropic blend, appetite control blend, and thermogenic herbal concentrates |
| 09/26/2002 | US20020136780 Microbicidal composition containing potassium sodium tartrate |
| 09/26/2002 | US20020136775 Aldosterone receptor blockers |
| 09/26/2002 | US20020136769 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 09/26/2002 | US20020136768 Quaternary ammonium compound, a hydrophilic film-forming agent, a hydrophobic waterproofing agent, a surfactant, and water for hand washing |
| 09/26/2002 | US20020136766 Doxycycline administered in three dosages forms of different release profiles, with Cmax being reached in < twelve hours |
| 09/26/2002 | US20020136765 Fluroquinilone antibiotic product, use and formulation thereof |
| 09/26/2002 | US20020136764 Antibiotic product, use and formulation thereof |
| 09/26/2002 | US20020136763 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 09/26/2002 | US20020136757 Preventing HIV vaginally or rectally by contacting a bodily fluid with polyquaternium, glycerin and a preservative system |
| 09/26/2002 | US20020136744 Sustained release drug dispersion delivery device |
| 09/26/2002 | US20020136731 Targeted therapeutic delivery of vitamin D compounds |
| 09/26/2002 | US20020136729 Combined physical and immunotherapy for cancer |